{"title":"Evaluation of the Radiation Oncologists’ Awareness and Needs about Geriatric Oncology: TROD-13-001 Study","authors":"F. Sert","doi":"10.5505/tjo.2023.3978","DOIUrl":"https://doi.org/10.5505/tjo.2023.3978","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71127505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OBJECTIVE The aim of this retrospective study was to experimentally estimate the embryo/fetal dose from non-conformal collimation computed tomography (CT) scans of pregnant women during thorax computed tomography (CCT) scans.
{"title":"Determination of Embryo/Fetus Doses of Pregnants in Thorax Computed Tomography Scan","authors":"mustafa demir","doi":"10.5505/tjo.2023.4066","DOIUrl":"https://doi.org/10.5505/tjo.2023.4066","url":null,"abstract":"OBJECTIVE The aim of this retrospective study was to experimentally estimate the embryo/fetal dose from non-conformal collimation computed tomography (CT) scans of pregnant women during thorax computed tomography (CCT) scans.","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135595153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anxiety, Depression, and Outbreak Anxiety and Related Factors in Patients with Cancer Receiving Radiotherapy during the COVID-19 Pandemic","authors":"H. Hali̇s","doi":"10.5505/tjo.2023.3810","DOIUrl":"https://doi.org/10.5505/tjo.2023.3810","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OBJECTIVE Glioblastoma (GBM) is the most aggressive primary brain tumor. Despite all treatments, very few have long-term survival. This retrospective study aimed to investigate the clinicopathological features, treat-ment modalities, and factors affecting survival in GBM patients with short-and long-term survival.
{"title":"Comparison of Prognostic Factors in Glioblastoma Patients with Short- and Long-term Survival","authors":"berrin benli yavuz","doi":"10.5505/tjo.2023.4057","DOIUrl":"https://doi.org/10.5505/tjo.2023.4057","url":null,"abstract":"OBJECTIVE Glioblastoma (GBM) is the most aggressive primary brain tumor. Despite all treatments, very few have long-term survival. This retrospective study aimed to investigate the clinicopathological features, treat-ment modalities, and factors affecting survival in GBM patients with short-and long-term survival.","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135595132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OBJECTIVE The primary objective in operable breast cancer (BC) is to achieve a pathological complete response (pCR). Although some markers can predict pCR, there is still a need for additional factors. METHODS We retrospectively analyzed patients with early BC patients treated with neoadjuvant systemic treatment (NST) at the one academic center. Baseline neutrophile/lymphocyte ratio (NLR) and the maximum standardized uptake value (SUV max ) were analyzed before surgery and their relationship to pCR was determined. RESULTS Ninety-nine patients were included in our analysis. Overall, 36 patients (36.4% of the total) achieved pCR, while 63 patients (63.6% of the total) did not. High SUV max at baseline was associated with worse prognostic factors, including larger tumor size, high grade, negative ER, and triple-negative breast cancer (TNBC). The median NLR was 1.85 for patients with pCR and 1.90 for those without pCR (p=0.392). Patients with pCR had a higher median baseline SUV max than those with residual tumors (14.5 vs. 10, respectively, p=0.023).
{"title":"Neutrophil-lymphocyte Ratio and Standardized Uptake Value of 18F-fluorodeoxyglucose Positron Emission Tomography for Prediction of Neoadjuvant Therapy Responses in Patients with Early-stage Breast Cancer","authors":"gülin alkan şen","doi":"10.5505/tjo.2023.4108","DOIUrl":"https://doi.org/10.5505/tjo.2023.4108","url":null,"abstract":"OBJECTIVE The primary objective in operable breast cancer (BC) is to achieve a pathological complete response (pCR). Although some markers can predict pCR, there is still a need for additional factors. METHODS We retrospectively analyzed patients with early BC patients treated with neoadjuvant systemic treatment (NST) at the one academic center. Baseline neutrophile/lymphocyte ratio (NLR) and the maximum standardized uptake value (SUV max ) were analyzed before surgery and their relationship to pCR was determined. RESULTS Ninety-nine patients were included in our analysis. Overall, 36 patients (36.4% of the total) achieved pCR, while 63 patients (63.6% of the total) did not. High SUV max at baseline was associated with worse prognostic factors, including larger tumor size, high grade, negative ER, and triple-negative breast cancer (TNBC). The median NLR was 1.85 for patients with pCR and 1.90 for those without pCR (p=0.392). Patients with pCR had a higher median baseline SUV max than those with residual tumors (14.5 vs. 10, respectively, p=0.023).","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135595148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Rare Case of Adult Embryonel Rabdomyosarcoma Including the Mandible","authors":"rümeysa şendişçi gök","doi":"10.5505/tjo.2023.3893","DOIUrl":"https://doi.org/10.5505/tjo.2023.3893","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Factors Affecting the Quality of Life in Breast Cancer Patients Undergoing Radiotherapy","authors":"Seher Bahar","doi":"10.5505/tjo.2023.3894","DOIUrl":"https://doi.org/10.5505/tjo.2023.3894","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71127203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dosimetric Evaluation of Auricular Contour Correction Effects on VMAT Nasopharynx Cancer Treatment","authors":"S. Karacam","doi":"10.5505/tjo.2023.4034","DOIUrl":"https://doi.org/10.5505/tjo.2023.4034","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71127246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response Prediction in Lung SBRT with Artificial Intelligence","authors":"M. Yakar","doi":"10.5505/tjo.2023.4008","DOIUrl":"https://doi.org/10.5505/tjo.2023.4008","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71127453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
SUMMARY Patients undergoing radiotherapy for malignancies in the head-and-neck region are prone to experiencing a range of dental complications. Osteoradionecrosis of the jaw (ORNJ) is a noteworthy complication that occurs infrequently but carries substantial significance, as evidenced by reported occurrence rates ranging from 2% to 22%. ORNJ is distinguished by bone necrosis and the inability to heal properly for at least 3 months. In the majority of cases, ORNJ typically demonstrates a gradual progression characterized by the subsequent development of infections, intra-or extra-oral fistulas, and bone necrosis with or without pathological fractures. There exists a multitude of risk factors that have been postulated to be associated with ORNJ. The literature extensively documents the influence of dental interventions on the progression of ORNJ; however, it continues to be a topic of continuing multidisciplinary debate. Establishing multidisciplinary collaborations that organize data and develop guidelines will be valuable for healthcare professionals operating in this specialized and relatively unfamiliar field. Therefore, this review has identified eleven key facts about dental safety precautions to prevent ORNJ and is prepared to give a clear and concise message to reduce the current uncertainty to provide recommendations, explanations, and measures.
{"title":"Important Considerations for Dental Safety to Prevent Osteoradionecrosis of the Jaws","authors":"efsun somay","doi":"10.5505/tjo.2023.4112","DOIUrl":"https://doi.org/10.5505/tjo.2023.4112","url":null,"abstract":"SUMMARY Patients undergoing radiotherapy for malignancies in the head-and-neck region are prone to experiencing a range of dental complications. Osteoradionecrosis of the jaw (ORNJ) is a noteworthy complication that occurs infrequently but carries substantial significance, as evidenced by reported occurrence rates ranging from 2% to 22%. ORNJ is distinguished by bone necrosis and the inability to heal properly for at least 3 months. In the majority of cases, ORNJ typically demonstrates a gradual progression characterized by the subsequent development of infections, intra-or extra-oral fistulas, and bone necrosis with or without pathological fractures. There exists a multitude of risk factors that have been postulated to be associated with ORNJ. The literature extensively documents the influence of dental interventions on the progression of ORNJ; however, it continues to be a topic of continuing multidisciplinary debate. Establishing multidisciplinary collaborations that organize data and develop guidelines will be valuable for healthcare professionals operating in this specialized and relatively unfamiliar field. Therefore, this review has identified eleven key facts about dental safety precautions to prevent ORNJ and is prepared to give a clear and concise message to reduce the current uncertainty to provide recommendations, explanations, and measures.","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135595143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：